Novelion Therapeutics Inc  

(Public, TSE:NVLN)   Watch this stock  
Find more results for TSE:QLT
2.45
-0.18 (-6.84%)
Dec 2 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 2.45 - 2.95
52 week 1.60 - 3.88
Open 2.95
Vol / Avg. 1,495.00/4,223.00
Mkt cap 138.94M
P/E     -
Div/yield     -
EPS     -
Shares     -
Beta     -
Inst. own     -
Feb 23, 2017
Q4 2016 QLT Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Nov 1, 2016
Q3 2016 QLT Inc Earnings Release
  

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -28.77% -15.06%
Return on average equity -30.77% -15.45%
Employees 23 -
CDP Score - -

Address

887 Great Northern Way Suite 250
VANCOUVER, BC V5T 4T5
Canada
+1-604-7077000 (Phone)
+1-604-7077001 (Fax)

Website links

Description

Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with rare diseases. The Company is focused on advancing its portfolio of rare disease therapies by investing in science and clinical development. The Company holds a portfolio of products through its subsidiary, Aegerion Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. The Company's portfolio of products include MYALEPT and JUXTAPID. The Company is also developing zuretinol acetate for the treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes.

Officers and directors

Jason M. Aryeh Independent Chairman of the Board
Age: 47
Geoffrey F. Cox Ph.D. Interim Chief Executive Officer, Director
Age: 71
Glen Ibbott Chief Financial Officer, Senior Vice President - Finance, Principal Accounting Officer
Age: 52
John W. Kozarich Ph.D. Independent Director
Age: 66
Jeffrey A. Meckler Independent Director
Age: 48
Stephen L. Sabba M.D. Independent Director
Age: 56
John C. Thomas Jr. Independent Director
Age: 61